Patent · US Active

Benzopyrazole compound used as RHO kinase inhibitor

US11345678B2 · kind B2 · utility

1Cited by

1References

19Claims

0Family size

Assignee

Medshine Discovery Inc. · CN

Inventors

Lingyun WU · Shanghai, CN
Jun Yin · Sichuan, CN
Cailin WANG · Shanghai, CN
Zheming XIAO · Shanghai, CN
Jian Li · Shanghai, CN
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	Apr 18, 2019
Grant date	May 31, 2022
Priority date	—
Expiry date	Apr 18, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to a benzopyrazole compound used as RHO kinase inhibitor, a pharmaceutical composition and uses thereof for preparing an RHO kinase inhibiting drug, and more specifically to said compound of formula (I-1), a pharmaceutically acceptable salt and isomer thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.